Literature DB >> 15774461

Recycling of the membrane-anchored chemokine, CX3CL1.

Guang-Ying Liu1, Vathany Kulasingam, R Todd Alexander, Nicolas Touret, Alan M Fong, Dhavalkumar D Patel, Lisa A Robinson.   

Abstract

CX(3)CL1 (fractalkine) plays an important role in inflammation by acting as both chemoattractant and as an adhesion molecule. As for other chemokines, expression of CX(3)CL1 is known to be regulated at the level of transcription and translation. The unique transmembrane structure of CX(3)CL1 raises the possibility of additional functional regulation by altering its abundance at the cell surface. This could be accomplished in principle by changes in traffic between subcellular compartments. To analyze this possibility we examined the subcellular distribution of CX(3)CL1 in human ECV-304 cells stably expressing untagged or green fluorescent protein-tagged forms of the chemokine. CX(3)CL1 was present in two distinct compartments, diffusely on the plasma membrane and in a punctate juxtanuclear compartment. The latter shared some features with, yet was distinct from the conventional endocytic pathway and may represent a specialized recycling subcompartment. Accordingly, surface CX(3)CL1 was found to be in dynamic equilibrium with the juxtanuclear vesicular compartment. Intracellular CX(3)CL1 co-localized with the SNARE (soluble N-ethylmaleimide factor attachment protein receptor) proteins syntaxin-13 and VAMP-3. Cleavage of VAMP-3 by tetanus toxin or impairment of syntaxin-13 function by expression of a dominant-negative allele inhibited the ability of internalized CX(3)CL1 to traffic back to the plasma membrane. These data demonstrate the existence of a dynamic, SNARE-mediated recycling of CX(3)CL1 from the cell surface to and from an endomembrane storage compartment. The intracellular storage depot may serve as a source of the chemokine that could be rapidly mobilized by stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774461     DOI: 10.1074/jbc.M413073200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. Role of the transmembrane domain.

Authors:  Patricia Hermand; Frédéric Pincet; Stéphanie Carvalho; Hervé Ansanay; Eric Trinquet; Mehdi Daoudi; Christophe Combadière; Philippe Deterre
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

2.  Genetic background of psoriasis.

Authors:  Hani A Alshobaili; Muhammad Shahzad; Abdullah Al-Marshood; Alsayed Khalil; Ahmad Settin; Issam Barrimah
Journal:  Int J Health Sci (Qassim)       Date:  2010-01

3.  CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.

Authors:  Whitney L Jamieson; Saori Shimizu; Julia A D'Ambrosio; Olimpia Meucci; Alessandro Fatatis
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

4.  Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.

Authors:  Céline Callewaere; Brigitte Fernette; Danièle Raison; Patricia Mechighel; Arlette Burlet; André Calas; Patrick Kitabgi; Stéphane Mélik Parsadaniantz; William Rostène
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

5.  Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases.

Authors:  Yi-Wei Huang; Paul Su; Guang Ying Liu; Min Rui Crow; Deanna Chaukos; Harry Yan; Lisa A Robinson
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

6.  The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.

Authors:  Louise A Johnson; David G Jackson
Journal:  J Cell Sci       Date:  2013-09-04       Impact factor: 5.285

7.  CX3CL1, a chemokine finely tuned to adhesion: critical roles of the stalk glycosylation and the membrane domain.

Authors:  Mariano A Ostuni; Julie Guellec; Patricia Hermand; Pauline Durand; Christophe Combadière; Frédéric Pincet; Philippe Deterre
Journal:  Biol Open       Date:  2014-11-13       Impact factor: 2.422

8.  Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.

Authors:  Sarah L Roche; Alice C Wyse-Jackson; Violeta Gómez-Vicente; Pedro Lax; Ana M Ruiz-Lopez; Ashleigh M Byrne; Nicolás Cuenca; Thomas G Cotter
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

9.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain.

Authors:  Anna K Clark; Ping K Yip; John Grist; Clive Gentry; Amelia A Staniland; Fabien Marchand; Maliheh Dehvari; Glen Wotherspoon; Janet Winter; Jakir Ullah; Stuart Bevan; Marzia Malcangio
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

10.  CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.

Authors:  Marina Zieger; Peter K Ahnelt; Pavel Uhrin
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.